The Current

Bionics Institute Autumn Newsletter

Innovation – the drive to uncover new ways of doing things - lies at the heart of the Bionics Institute.

Our talented researchers and engineers are hard-wired to find new ways to diagnose and treat the world’s most challenging medical conditions. Bionics Institute achievements are derived from their innovation.

This includes, among many others, a novel system to enhance deep brain stimulation for Parkinson’s disease; a vagus nerve stimulation device to reduce inflammation in Crohn’s disease; new techniques to diagnose previously undiagnosed deafness in infants; and novel therapies to give back hearing in those who have lost it due to age and/or noise exposure.

In this newsletter, we hear from Dr Mehrnaz Shoushtarian who has developed a new way to use near-infrared spectroscopy to provide a much-needed objective measure of tinnitus.

We also take a deep dive with our data analytics lead Dr Gautam Balasubramanian, who is developing new machine learning and signal processing algorithms for software used in devices, such as the EarGenie™ infant hearing diagnostic tool.

In a recent survey, 87% of our staff said they rate the Bionics Institute as exceptional in its support for innovation

One element of this support is the Bionics Incubator Fund, which provides seed funding to researchers who pitch a great idea.

One fabulous idea is the adaption of our vagus nerve stimulation device to treat rheumatoid arthritis, which is progressing well towards clinical trials.

Your support for early-stage research at the Bionics Institute is vital to translate amazing ideas like these into new diagnostic tools and life-changing treatments.

We hope you will continue to support Innovation for Life at the Bionics Institute.

Read our Autumn newsletter

Robert Klupacs

CEO, Bionics Institute